CN111748522A - Stem cell culture medium and application thereof - Google Patents
Stem cell culture medium and application thereof Download PDFInfo
- Publication number
- CN111748522A CN111748522A CN202010760134.9A CN202010760134A CN111748522A CN 111748522 A CN111748522 A CN 111748522A CN 202010760134 A CN202010760134 A CN 202010760134A CN 111748522 A CN111748522 A CN 111748522A
- Authority
- CN
- China
- Prior art keywords
- parts
- culture medium
- cell culture
- stem cell
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 69
- 239000006143 cell culture medium Substances 0.000 title claims abstract description 32
- 239000000126 substance Substances 0.000 claims abstract description 31
- 150000002632 lipids Chemical class 0.000 claims abstract description 30
- 239000000654 additive Substances 0.000 claims abstract description 27
- 230000000996 additive effect Effects 0.000 claims abstract description 27
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 238000000605 extraction Methods 0.000 claims abstract description 14
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000006166 lysate Substances 0.000 claims abstract description 13
- 239000003797 essential amino acid Substances 0.000 claims abstract description 11
- 239000004017 serum-free culture medium Substances 0.000 claims abstract description 8
- 235000020776 essential amino acid Nutrition 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- 235000013399 edible fruits Nutrition 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 229940088598 enzyme Drugs 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 13
- 239000000419 plant extract Substances 0.000 claims description 13
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 9
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 9
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 9
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 9
- 235000019743 Choline chloride Nutrition 0.000 claims description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000005642 Oleic acid Substances 0.000 claims description 9
- 229930003779 Vitamin B12 Natural products 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 9
- 229960003178 choline chloride Drugs 0.000 claims description 9
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 9
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 229960000367 inositol Drugs 0.000 claims description 9
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 9
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 9
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 9
- 235000019136 lipoic acid Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 235000019192 riboflavin Nutrition 0.000 claims description 9
- 239000002151 riboflavin Substances 0.000 claims description 9
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 9
- 229960002663 thioctic acid Drugs 0.000 claims description 9
- 235000019163 vitamin B12 Nutrition 0.000 claims description 9
- 239000011715 vitamin B12 Substances 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 244000131360 Morinda citrifolia Species 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 235000017524 noni Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 101710130006 Beta-glucanase Proteins 0.000 claims description 7
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 235000008898 Morinda citrifolia Nutrition 0.000 claims description 7
- 108010059820 Polygalacturonase Proteins 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 7
- 229940059442 hemicellulase Drugs 0.000 claims description 7
- 108010002430 hemicellulase Proteins 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 14
- 210000001519 tissue Anatomy 0.000 abstract description 9
- 230000004069 differentiation Effects 0.000 abstract description 7
- 230000035755 proliferation Effects 0.000 abstract description 7
- 238000004113 cell culture Methods 0.000 abstract description 6
- 210000000056 organ Anatomy 0.000 abstract description 6
- 210000003954 umbilical cord Anatomy 0.000 abstract description 6
- 230000003321 amplification Effects 0.000 abstract description 4
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 4
- 210000000577 adipose tissue Anatomy 0.000 abstract description 3
- 210000001185 bone marrow Anatomy 0.000 abstract description 3
- -1 compound vitamin Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000002293 adipogenic effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000012679 serum free medium Substances 0.000 description 5
- TZSMWSKOPZEMAJ-UHFFFAOYSA-N bis[(2-methoxyphenyl)methyl] carbonate Chemical compound COC1=CC=CC=C1COC(=O)OCC1=CC=CC=C1OC TZSMWSKOPZEMAJ-UHFFFAOYSA-N 0.000 description 3
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000012192 staining solution Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000012606 in vitro cell culture Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a stem cell culture medium, which belongs to the technical field of stem cell culture and comprises the following substances: serum-free culture medium, platelet lysate, glutamine, non-essential amino acids, compound vitamins, lipids and plant extraction additive. The cell culture medium is suitable for culturing stem cells separated from tissues or organs with stem cells such as bone marrow, umbilical cords, adipose tissues and the like, can improve the amplification speed of the cells by 4-6 times, does not influence the differentiation potential of the cells, and obviously improves the purity and proliferation capacity of stem cell culture.
Description
Technical Field
The invention belongs to the technical field of stem cell culture, and particularly relates to a stem cell culture medium and application thereof.
Background
Many researches show that the stem cells can not only self-renew, but also differentiate into other functional cells under proper conditions, so that the stem cells are expected to become an effective means for treating human intractable diseases. However, stem cells are present in a very small amount in normal adult tissues, and how to rapidly expand and culture stem cells in vitro is an important technique for studying the mechanism of action of stem cells and exploring therapeutic methods for treating human diseases.
Stem cells are present in minor amounts, but are widely distributed in various tissues and organs of mammals, including, but not limited to, bone marrow, umbilical cord, adipose tissue, brain tissue, retina, heart, liver, lung, and skin. Numerous studies have shown that these low stem cells can be further expanded in vitro by appropriate methods, one of the most common stem cell culture media being medium supplemented with 10% fetal bovine serum. However, stem cells cultured in this medium not only grow relatively slowly, but also have a greatly reduced potential to differentiate into functional cells after more than 5 passages.
The application numbers are: 201810430129.4 discloses a stem cell culture medium, its application and stem cell culture method, which ensures the expansion stability of stem cells and shortens the culture time. However, the culture effect of stem cells of different tissues is unstable, and further improvement and enhancement are still needed.
Disclosure of Invention
The invention aims to provide a stem cell culture medium and application thereof.
The technical purpose of the invention is realized by the following technical scheme:
a stem cell culture medium comprises the following substances in parts by weight:
85-90 parts of a serum-free culture medium, 7-10 parts of a platelet lysate, 2-3 parts of glutamine, 3-5 parts of non-essential amino acid, 2-4 parts of vitamin complex, 1-3 parts of lipid and 0.5-1 part of a plant extraction additive.
Preferably, the composition comprises the following substances in parts by weight:
86-88 parts of serum-free culture medium, 8-9 parts of platelet lysate, 2.3-2.6 parts of glutamine, 3.5-4.5 parts of non-essential amino acid, 2.5-3.5 parts of vitamin complex, 1.5-2.5 parts of lipid and 0.6-0.8 part of plant extraction additive.
More preferably, the following substances are included in corresponding parts by weight:
87 parts of serum-free culture medium, 8.5 parts of platelet lysate, 2.5 parts of glutamine, 4 parts of nonessential amino acid, 3 parts of composite vitamin, 2 parts of lipid and 0.7 part of plant extraction additive.
Further, the compound vitamin comprises the following substances in parts by weight: 10-14 parts of choline chloride, 3-6 parts of folic acid, 2-5 parts of inositol, 4-8 parts of nicotinamide, 6-12 parts of riboflavin, 7-11 parts of vitamin B12, 20-25 parts of vitamin C and 15-20 parts of vitamin E.
Preferably, the compound vitamin comprises the following substances in parts by weight: 12 parts of choline chloride, 5 parts of folic acid, 4 parts of inositol, 6 parts of nicotinamide, 9 parts of riboflavin, 9 parts of vitamin B12, 24 parts of vitamin C and 18 parts of vitamin E.
Furthermore, the lipid is composed of the following substances in parts by weight: 20-25 parts of oleic acid, 5-10 parts of cholesterol, 4-8 parts of linoleic acid, 3-6 parts of lipoic acid and 1-5 parts of lipid.
Furthermore, the lipid is composed of the following substances in parts by weight: 24 parts of oleic acid, 8 parts of cholesterol, 6 parts of linoleic acid, 5 parts of lipoic acid and 3 parts of lipid.
Further, the preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding a complex enzyme accounting for 0.3-0.5% of the total mass of the fruit pulp into the fruit pulp, controlling the enzymolysis temperature to be 38-43 ℃, and performing enzymolysis treatment for 2-2.5 hours to obtain an enzymolysis liquid for later use; the compound enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to a weight ratio of 5-7: 4-6: 1-3: 2-4;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) and filtering the supernatant to obtain the plant extract additive.
Further, the aperture of the filter membrane is controlled to be 0.7-5 μm during the filtration treatment in the step (4).
The application of a stem cell culture medium is used for culturing stem cells.
Compared with the prior art, the invention has the following advantages:
the invention changes the raw material components and the proportion ratio of the stem cell culture medium, wherein the serum-free culture medium is favorable for improving the amplification purity of stem cells, so that vascular endothelial cells, fiber cells and the like can not grow, the added platelet lysate contains factors required by the proliferation and division of the stem cells, the added glutamine and non-essential amino acid provide the required nutrient supply for the stem cells, the compound vitamins and lipids also protect the rapid stability of the growth of the stem cells, the added plant extraction additive is extracted from noni fruits serving as a raw material and is rich in an extracting agent of active ingredients such as silonin and the like, and the substance can promote the growth of the cells, activate and improve the activity of tyrosinase, eliminate free radicals and enhance the service life and the amplification capacity of the cells. Under the synergistic effect of the raw material components, the cell culture medium is suitable for culturing stem cells separated from tissues or organs with stem cells such as bone marrow, umbilical cord, adipose tissue and the like, can improve the amplification speed of the cells by 4-6 times, does not influence the differentiation potential of the cells, obviously improves the purity and the proliferation capacity of stem cell culture, and has great popularization and application values.
Detailed Description
The following will clearly and completely describe the technical solutions of the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A stem cell culture medium comprises the following substances in parts by weight:
components | Parts by weight |
Serum-free medium | 85 portions of |
Platelet lysate | 7 portions of |
Glutamine | 2 portions of |
Non-essential amino acids | 3 portions of |
Compound vitamin | 2 portions of |
Lipids | 1 part of |
Plant extract additive | 0.5 portion |
The compound vitamin comprises the following substances in parts by weight: 10 parts of choline chloride, 3 parts of folic acid, 2 parts of inositol, 4 parts of nicotinamide, 6 parts of riboflavin, 7 parts of vitamin B12, 20 parts of vitamin C and 15 parts of vitamin E.
The lipid comprises the following substances in parts by weight: 20 parts of oleic acid, 5 parts of cholesterol, 4 parts of linoleic acid, 3 parts of lipoic acid and 1 part of lipid.
The preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding complex enzyme with the total mass of 0.3% into the fruit pulp, controlling the enzymolysis temperature to be 38 ℃, and performing enzymolysis treatment for 2 hours to obtain enzymolysis liquid for later use; the complex enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to the weight ratio of 5:4:1: 2;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) filtering the supernatant to obtain filter membrane with pore diameter of 0.7 μm, and collecting the plant extract additive.
Example 2
A stem cell culture medium comprises the following substances in parts by weight:
components | Parts by weight |
Serum-free medium | 86 portions of |
Platelet lysate | 8 portions of |
Glutamine | 2.3 parts of |
Non-essential amino acids | 3.5 parts of |
Compound vitamin | 2.5 parts of |
Lipids | 1.5 parts of |
Plant extract additive | 0.6 part |
The compound vitamin comprises the following substances in parts by weight: 10 parts of choline chloride, 5 parts of folic acid, 2 parts of inositol, 4 parts of nicotinamide, 6 parts of riboflavin, 9 parts of vitamin B12, 20 parts of vitamin C and 15 parts of vitamin E.
The lipid comprises the following substances in parts by weight: 20 parts of oleic acid, 8 parts of cholesterol, 6 parts of linoleic acid, 3 parts of lipoic acid and 1 part of lipid.
The preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding complex enzyme with the total mass of 0.3% into the fruit pulp, controlling the enzymolysis temperature to be 40 ℃, and performing enzymolysis treatment for 2 hours to obtain enzymolysis liquid for later use; the compound enzyme is prepared by mixing cellulase, hemicellulase, beta-glucanase and pectinase according to the weight ratio of 5:4:1: 3, mixing;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) filtering the supernatant to obtain filter membrane with pore diameter of 1 μm, and collecting the plant extract additive.
Example 3
A stem cell culture medium comprises the following substances in parts by weight:
components | Parts by weight |
Serum-free medium | 87 portions |
Platelet lysate | 8.5 parts of |
Glutamine | 2.5 parts of |
Non-essential amino acids | 4 portions of |
Compound vitamin | 3 portions of |
Lipids | 2 portions of |
Plant extract additive | 0.7 portion of |
The compound vitamin comprises the following substances in parts by weight: 12 parts of choline chloride, 5 parts of folic acid, 4 parts of inositol, 6 parts of nicotinamide, 9 parts of riboflavin, 9 parts of vitamin B12, 24 parts of vitamin C and 18 parts of vitamin E.
The lipid comprises the following substances in parts by weight: 24 parts of oleic acid, 8 parts of cholesterol, 6 parts of linoleic acid, 5 parts of lipoic acid and 3 parts of lipid.
The preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding complex enzyme with the total mass of 0.4% into the fruit pulp, controlling the enzymolysis temperature at 40 ℃, and performing enzymolysis treatment for 2.3h to obtain enzymolysis liquid for later use; the complex enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to the weight ratio of 6:5:2: 3;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) filtering the supernatant to obtain filter membrane with pore diameter of 2 μm, and collecting the plant extract additive.
Example 4
A stem cell culture medium comprises the following substances in parts by weight:
components | Parts by weight |
Serum-free medium | 88 portions of |
Platelet lysate | 9 portions of |
Glutamine | 2.6 parts of |
Non-essential amino acids | 4.5 parts of |
Compound vitamin | 3.5 parts of |
Lipids | 2.5 parts of |
Plant extract additive | 0.8 portion of |
The compound vitamin comprises the following substances in parts by weight: 12 parts of choline chloride, 6 parts of folic acid, 5 parts of inositol, 8 parts of nicotinamide, 10 parts of riboflavin, 9 parts of vitamin B12, 25 parts of vitamin C and 20 parts of vitamin E.
The lipid comprises the following substances in parts by weight: 25 parts of oleic acid, 8 parts of cholesterol, 8 parts of linoleic acid, 5 parts of lipoic acid and 4 parts of lipid.
The preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding complex enzyme with the total mass of 0.5% into the fruit pulp, controlling the enzymolysis temperature at 40 ℃, and performing enzymolysis for 2.3h to obtain enzymolysis liquid for later use; the complex enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to the weight ratio of 7:6:3: 3;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) filtering the supernatant to obtain filter membrane with pore diameter of 4 μm, and collecting the plant extract additive.
Example 5
A stem cell culture medium comprises the following substances in parts by weight:
the compound vitamin comprises the following substances in parts by weight: 14 parts of choline chloride, 6 parts of folic acid, 5 parts of inositol, 8 parts of nicotinamide, 12 parts of riboflavin, 11 parts of vitamin B12, 25 parts of vitamin C and 20 parts of vitamin E.
The lipid comprises the following substances in parts by weight: 25 parts of oleic acid, 10 parts of cholesterol, 8 parts of linoleic acid, 6 parts of lipoic acid and 5 parts of lipid.
The preparation method of the plant extraction additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding complex enzyme with the total mass of 0.5% into the fruit pulp, controlling the enzymolysis temperature at 43 ℃, and performing enzymolysis treatment for 2.5h to obtain enzymolysis liquid for later use; the complex enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to the weight ratio of 7:6:3: 4;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) filtering the supernatant to obtain filter membrane with pore diameter of 5 μm, and collecting the plant extract additive.
Comparative example 1
A stem cell culture medium comprises the following substances in parts by weight:
this comparative example 1 is compared to example 3 with the only difference that the plant extract additive components are omitted except that the process steps are the same.
The serum-free medium used in examples 1 to 5 and comparative example 1 was supplied by CellGenix corporation, Cat. 24803-; platelet lysate is supplied by the company commpass biological, cat #: PLS 2; glutamine is glutamine, Gln; non-essential amino acids are NEAA, non-essentialamic acid.
Control group
The application numbers are: 201810430129.4 discloses a stem cell culture medium.
In order to compare the effects of the invention, experiments on the proliferation acceleration effect of stem cells of different tissues are carried out, and the experiments specifically comprise:
1. test medium: stem cell culture media corresponding to example 2, comparative example 1, and control;
2. culturing a stem cell source: human stem cells (ADSC, BMSC, UMBSC) derived from three tissues and organs, namely fat, marrow and umbilical cord;
3. in vitro cell culture experiments: the cell inoculation density is controlled to be 10-20%, and after inoculation, a culture medium is added for culture (37 ℃, 5% CO)2);
The cell density is measured every 8 hours by an MTT method, and the specific experimental result data are shown in the following tables 1-3:
TABLE 1
TABLE 2
TABLE 3
As can be seen from the above tables 1 to 3, the culture medium corresponding to the embodiment 2 of the present invention can rapidly realize proliferation of stem cells, and has a good and stable proliferation promoting effect on different types of stem cells.
In order to further compare the effects of the invention, an experiment for analyzing the influence of the potency of the adipogenic cells is carried out, which specifically comprises the following steps:
1. test medium: stem cell culture media corresponding to example 2, comparative example 1, and control;
2. culturing a stem cell source: human stem cells (ADSC, BMSC, UMBSC) derived from three tissues and organs, namely fat, marrow and umbilical cord;
3. in vitro cell culture experiments: in order to further examine the influence of the stem cells on the differentiation potential after 10 generations of expansion by the culture medium described in the present invention, the differentiation experiments of adipogenic cells after the expansion of human stem cells (ADSC, BMSC, UMBSC) derived from three tissues and organs, fat, marrow and umbilical cord, were determined according to the Methods described in the literature (Methods in Molecular Biology,2011, Volume 702, Part 3, 193-; the specific method is that the stem cells are induced by replacing a adipogenic culture medium when the density of the stem cells is about 80 percent, and the adipogenic culture medium has the formula: DMEM/F12 medium with 1% FBS, 1mM dexamethasone, 200mM indomethacin, 0.5nM 3-isobutyl-1-methylxanthine (IBMX), 10mg/ml insulin. The solution was changed once every two days, and oil red O staining was performed two weeks after induction. The oil red O staining solution is prepared from oil red O, and the oil red O storage solution: weighing 0.5g of oil red O, adding into 100ml of isopropanol, and filtering for 0.22 mm; oil red O working fluid: and (4) sucking 6ml of oil red O storage liquid, adding into 4ml of distilled water, and uniformly mixing. The specific method is that after the adipogenic induction is successful, the culture medium is sucked out and washed for 2 times by PBS; adding newly-prepared oil red O staining solution for dyeing for 1 hour; the staining solution was removed, washed 3 times with PBS for 2min each time, and observed with a microscope. After the fat cells are stained, the number of positive cells is counted, and the data of the specific experiment result are shown in the following table 4:
as can be seen from the above Table 4, the culture medium of the present invention can well ensure the differentiation potential of stem cells, and even after 10 generations of expansion, the culture medium still has a cell differentiation rate of 90%, and compared with the existing matrix, the differentiation potential is significantly improved.
In conclusion, the stem cell culture medium can well ensure the differentiation potential of stem cells, obviously improve the purity and proliferation capacity of stem cell culture, and has great popularization and application values.
Claims (10)
1. A stem cell culture medium is characterized by comprising the following substances in parts by weight:
85-90 parts of a serum-free culture medium, 7-10 parts of a platelet lysate, 2-3 parts of glutamine, 3-5 parts of non-essential amino acid, 2-4 parts of vitamin complex, 1-3 parts of lipid and 0.5-1 part of a plant extraction additive.
2. The stem cell culture medium according to claim 1, comprising the following substances in parts by weight:
86-88 parts of serum-free culture medium, 8-9 parts of platelet lysate, 2.3-2.6 parts of glutamine, 3.5-4.5 parts of non-essential amino acid, 2.5-3.5 parts of vitamin complex, 1.5-2.5 parts of lipid and 0.6-0.8 part of plant extraction additive.
3. The stem cell culture medium according to claim 2, comprising the following substances in parts by weight:
87 parts of serum-free culture medium, 8.5 parts of platelet lysate, 2.5 parts of glutamine, 4 parts of nonessential amino acid, 3 parts of composite vitamin, 2 parts of lipid and 0.7 part of plant extraction additive.
4. The stem cell culture medium according to any one of claims 1 to 3, wherein the vitamin complex comprises the following substances in parts by weight: 10-14 parts of choline chloride, 3-6 parts of folic acid, 2-5 parts of inositol, 4-8 parts of nicotinamide, 6-12 parts of riboflavin, 7-11 parts of vitamin B12, 20-25 parts of vitamin C and 15-20 parts of vitamin E.
5. The stem cell culture medium according to claim 4, wherein the vitamin complex comprises the following substances in parts by weight: 12 parts of choline chloride, 5 parts of folic acid, 4 parts of inositol, 6 parts of nicotinamide, 9 parts of riboflavin, 9 parts of vitamin B12, 24 parts of vitamin C and 18 parts of vitamin E.
6. The stem cell culture medium according to any one of claims 1 to 3, wherein the lipid is composed of the following substances in parts by weight: 20-25 parts of oleic acid, 5-10 parts of cholesterol, 4-8 parts of linoleic acid, 3-6 parts of lipoic acid and 1-5 parts of lipid.
7. The stem cell culture medium of claim 6, wherein the lipid is comprised of, in parts by weight: 24 parts of oleic acid, 8 parts of cholesterol, 6 parts of linoleic acid, 5 parts of lipoic acid and 3 parts of lipid.
8. The stem cell culture medium according to any one of claims 1 to 3, wherein the preparation method of the plant extract additive comprises the following steps:
(1) cleaning Morinda citrifolia, juicing, and filtering to obtain fruit pulp for later use;
(2) adding a complex enzyme accounting for 0.3-0.5% of the total mass of the fruit pulp into the fruit pulp, controlling the enzymolysis temperature to be 38-43 ℃, and performing enzymolysis treatment for 2-2.5 hours to obtain an enzymolysis liquid for later use; the compound enzyme is prepared by correspondingly mixing cellulase, hemicellulase, beta-glucanase and pectinase according to a weight ratio of 5-7: 4-6: 1-3: 2-4;
(3) centrifuging the enzymolysis solution, collecting the centrifugate, and standing to obtain supernatant of the centrifugate for later use;
(4) and filtering the supernatant to obtain the plant extract additive.
9. The stem cell culture medium according to claim 8, wherein the pore size of the filter membrane in the filtration treatment in the step (4) is controlled to be 0.7 to 5 μm.
10. Use of a stem cell culture medium according to any one of claims 1 to 9 for culturing stem cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010760134.9A CN111748522A (en) | 2020-07-31 | 2020-07-31 | Stem cell culture medium and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010760134.9A CN111748522A (en) | 2020-07-31 | 2020-07-31 | Stem cell culture medium and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111748522A true CN111748522A (en) | 2020-10-09 |
Family
ID=72712748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010760134.9A Pending CN111748522A (en) | 2020-07-31 | 2020-07-31 | Stem cell culture medium and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111748522A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113106098A (en) * | 2021-04-21 | 2021-07-13 | 贵州医科大学 | Recombinant sequence for specifically expressing human beta globin in erythroid cells and application thereof |
CN116731984A (en) * | 2023-07-24 | 2023-09-12 | 合肥戬谷生物科技有限公司 | Editing tool for realizing base transversion based on TadA8e mutant and application |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102578508A (en) * | 2012-03-01 | 2012-07-18 | 刘善沪 | Preparation method of Noni fruit purification and fermentation liquid |
CN103060264A (en) * | 2012-12-20 | 2013-04-24 | 上海市第十人民医院 | Stem cell culture medium and application thereof and stem cell cultivation method |
CN103243070A (en) * | 2013-04-25 | 2013-08-14 | 刘小青 | Stem cell medium and application thereof |
US20140178987A1 (en) * | 2012-12-20 | 2014-06-26 | Shanghai Tenth People's Hospital | Stem cell culture medium and its applications as well as a stem cell culture method |
CN104830772A (en) * | 2015-05-28 | 2015-08-12 | 深圳富利鑫健康产业发展有限公司 | Hematopoietic stem cell culture medium and its application and stem cell cultivation method based on hematopoietic stem cell culture medium |
CN108220231A (en) * | 2018-01-23 | 2018-06-29 | 广州资生生物科技有限公司 | A kind of stem cell media and its preparation method and application |
CN108651929A (en) * | 2018-04-19 | 2018-10-16 | 南陵县葛业协会 | A kind of Noni fruit flavor chocolate jelly and preparation method thereof |
CN109907311A (en) * | 2019-04-01 | 2019-06-21 | 海南松吉云商科技有限公司 | A kind of Noni fruit compound fermentation method and its beautiful composite enzyme of promise |
-
2020
- 2020-07-31 CN CN202010760134.9A patent/CN111748522A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102578508A (en) * | 2012-03-01 | 2012-07-18 | 刘善沪 | Preparation method of Noni fruit purification and fermentation liquid |
CN103060264A (en) * | 2012-12-20 | 2013-04-24 | 上海市第十人民医院 | Stem cell culture medium and application thereof and stem cell cultivation method |
US20140178987A1 (en) * | 2012-12-20 | 2014-06-26 | Shanghai Tenth People's Hospital | Stem cell culture medium and its applications as well as a stem cell culture method |
CN103243070A (en) * | 2013-04-25 | 2013-08-14 | 刘小青 | Stem cell medium and application thereof |
CN104830772A (en) * | 2015-05-28 | 2015-08-12 | 深圳富利鑫健康产业发展有限公司 | Hematopoietic stem cell culture medium and its application and stem cell cultivation method based on hematopoietic stem cell culture medium |
CN108220231A (en) * | 2018-01-23 | 2018-06-29 | 广州资生生物科技有限公司 | A kind of stem cell media and its preparation method and application |
CN108651929A (en) * | 2018-04-19 | 2018-10-16 | 南陵县葛业协会 | A kind of Noni fruit flavor chocolate jelly and preparation method thereof |
CN109907311A (en) * | 2019-04-01 | 2019-06-21 | 海南松吉云商科技有限公司 | A kind of Noni fruit compound fermentation method and its beautiful composite enzyme of promise |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113106098A (en) * | 2021-04-21 | 2021-07-13 | 贵州医科大学 | Recombinant sequence for specifically expressing human beta globin in erythroid cells and application thereof |
CN113106098B (en) * | 2021-04-21 | 2022-04-01 | 贵州医科大学 | Recombinant sequence for specifically expressing human beta globin in erythroid cells and application thereof |
CN116731984A (en) * | 2023-07-24 | 2023-09-12 | 合肥戬谷生物科技有限公司 | Editing tool for realizing base transversion based on TadA8e mutant and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112322580B (en) | Application of serum-free medium for mesenchymal stem cells | |
US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
CN103243070B (en) | Stem cell medium and application thereof | |
EP2099901B1 (en) | Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells | |
CN109694851B (en) | Inducing composition and inducing differentiation culture solution of human mesenchymal stem cells, and in-vitro inducing method and application thereof | |
CN106854638B (en) | Method for inducing mesenchymal stem cells to differentiate into islet-like cells | |
CN112111448B (en) | Improved mesenchymal stem cell culture medium, bone marrow mesenchymal stem cell, and culture method and application thereof | |
CN107653225A (en) | A kind of culture medium and its amplification method for being used to expand human mesenchymal stem cell | |
CN108220230B (en) | Method for separating and culturing human adipose-derived stem cells | |
CN111748522A (en) | Stem cell culture medium and application thereof | |
US11840706B2 (en) | Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells | |
CN106929470A (en) | It is a kind of for derived mesenchymal stem cells in vitro culture and amplification serum free medium | |
CN113736731B (en) | Serum-free medium of adipose tissue-derived mesenchymal stem cells and preparation method and application thereof | |
CN116640727B (en) | Nutrient solution for improving cell viability and preparation method and application thereof | |
KR102281535B1 (en) | Generation of liver organoid from stem cells for hemophilia A treatment | |
CN105087475B (en) | A kind of method that cell culture fluid and its application and induction dental pulp stem cell break up to neural-like cells | |
CN115125192B (en) | Bone marrow supernatant and application thereof in cell culture | |
KR20210053725A (en) | Culture medium composition for culturing urine-derived stem cells, and method for culturing urine-derived stem cells by using same | |
CN115305232B (en) | Adipose-derived mesenchymal stem cell resuscitating culture solution and resuscitating method | |
CN113774019B (en) | Serum-free medium for umbilical cord blood mesenchymal stem cells, culture method and application thereof | |
CN106474157B (en) | Liver stem cell injection and preparation method thereof | |
CN114790443A (en) | Mesenchymal stem cell in-vitro culture method and culture medium thereof | |
CN111925986A (en) | Umbilical cord mesenchymal stem cell serum-free culture medium and preparation method thereof | |
JPS63304978A (en) | Method for breeding epithelial cell | |
KR102400263B1 (en) | A stem cell culture method for enhancement of stem cell initial yield |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201009 |
|
RJ01 | Rejection of invention patent application after publication |